0000950170-24-035939.txt : 20240325
0000950170-24-035939.hdr.sgml : 20240325
20240325161953
ACCESSION NUMBER: 0000950170-24-035939
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240321
FILED AS OF DATE: 20240325
DATE AS OF CHANGE: 20240325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital VII, L.P.
CENTRAL INDEX KEY: 0001750266
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 24779471
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures VII GP, L.P.
CENTRAL INDEX KEY: 0001777655
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 24779470
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures VII GP-GP, LLC
CENTRAL INDEX KEY: 0001777656
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 24779469
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LENZ Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 844867570
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 445 MARINE VIEW AVE SUITE 320
CITY: DEL MAR
STATE: CA
ZIP: 92014
BUSINESS PHONE: 858-925-7000
MAIL ADDRESS:
STREET 1: 445 MARINE VIEW AVE SUITE 320
CITY: DEL MAR
STATE: CA
ZIP: 92014
FORMER COMPANY:
FORMER CONFORMED NAME: Graphite Bio, Inc.
DATE OF NAME CHANGE: 20210312
FORMER COMPANY:
FORMER CONFORMED NAME: Integral Medicines, Inc.
DATE OF NAME CHANGE: 20200622
3
1
ownership.xml
3
X0206
3
2024-03-21
0
0001815776
LENZ Therapeutics, Inc.
LENZ
0001750266
Versant Venture Capital VII, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
false
false
true
false
0001777655
Versant Ventures VII GP, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
false
false
true
false
0001777656
Versant Ventures VII GP-GP, LLC
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
false
false
true
false
Common Stock
1598789
D
Warrant (Right to Buy)
10.64
2024-03-21
2027-10-30
Common Stock
70534
D
These securities were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("Merger Sub"), and Lenz Therapeutics, Inc., a Delaware corporation ("LENZ"), pursuant to which the Merger Sub merged with and into LENZ (the "Merger"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger.
These securities are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII disclaims beneficial ownership of the shares held by VVC VII, except to the extent of their respective pecuniary interests therein.
Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
2024-03-25
Versant Ventures VII GP, L.P., By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
2024-03-25
Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
2024-03-25